undamentalytics Newsletter

Pfreundschuh Peter P.: insider trades

Chief financial officer at 3 companies we cover. No open-market purchases and 10 sales not made under a pre-set plan, reported from August 22, 2019 to February 22, 2024.

What happened after Pfreundschuh Peter P.’s sales?

After their sales, the shares moved −50.6% against the index over 12 months on average (a negative figure means selling was the right call); 100% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Pfreundschuh Peter P.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 8 −8.3% −8.2% 88% 4 −0.81 0.48 No reliable evidence
Sales, 12 months after the report 8 −50.6% −49.8% 100% 4 −8.72 0.003 Some evidence: seller right
Sales, 12 months after the trade 8 −48.1% −46.0% 100% 4 −9.42 0.003 Some evidence: seller right

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Urogen Pharma Ltd. URGN Chief Financial Officer06August 22, 2019October 16, 2020
Korro Bio, Inc. KRRO Chief Financial Officer02February 18, 2022February 23, 2022
Voyager Therapeutics, Inc. VYGR Chief Financial Officer02October 5, 2023February 22, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 22, 2024February 21, 2024 VYGR Sale $28,079 −4.9%−68.1%−68.0%
October 5, 2023October 3, 2023 VYGR Sale $94,833 +11.3%−39.7%−51.5%
February 23, 2022February 18, 2022 KRRO Sale $10,891 not yetnot yetnot yet
February 18, 2022February 16, 2022 KRRO Sale $10,888 not yetnot yetnot yet
October 16, 2020October 15, 2020 URGN Sale $52,247 −22.2%−58.8%−55.2%
September 1, 2020September 1, 2020 URGN Sale $11,615 −5.8%−39.1%−45.1%
February 24, 2020February 20, 2020 URGN Sale $10,685 −7.9%−53.1%−34.8%
January 28, 2020January 27, 2020 URGN Sale $19,530 −12.4%−46.3%−39.2%
November 22, 2019November 20, 2019 URGN Sale $10,057 −8.5%−50.8%−44.1%
August 22, 2019August 20, 2019 URGN Sale $46,827 −16.2%−48.8%−47.0%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Pfreundschuh Peter P. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.